| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1028933312 |
| P356 | DOI | 10.1186/2110-5820-3-16 |
| P932 | PMC publication ID | 3698065 |
| P698 | PubMed publication ID | 23725411 |
| P5875 | ResearchGate publication ID | 237001653 |
| P2093 | author name string | Oliver Karam | |
| Sonia Labarinas | |||
| Delphine Arni | |||
| P2860 | cites work | Cytokine generation in whole blood, leukocyte-depleted and temporarily warmed red blood cell concentrates | Q74621016 |
| Fresh-frozen plasma and platelet transfusions are associated with development of acute lung injury in critically ill medical patients | Q80075820 | ||
| Justifying the clinical use of fresh frozen plasma - an audit | Q80224240 | ||
| Why do physicians request fresh frozen plasma? | Q80470290 | ||
| A multifaceted strategy to reduce inappropriate use of frozen plasma transfusions in the intensive care unit | Q83721196 | ||
| Stability of coagulation factors in plasma prepared after a 24-hour room temperature hold | Q84094955 | ||
| Transfusion-associated circulatory overload after plasma transfusion | Q84564297 | ||
| Thrombelastography (TEG) or thromboelastometry (ROTEM) to monitor haemotherapy versus usual care in patients with massive transfusion | Q24235742 | ||
| Plasma components: properties, differences, and uses | Q33401173 | ||
| Is fresh-frozen plasma clinically effective? An update of a systematic review of randomized controlled trials | Q34132303 | ||
| A comparison of albumin and saline for fluid resuscitation in the intensive care unit | Q34548188 | ||
| Quality of therapeutic plasma-requirements for marketing authorization | Q34962498 | ||
| Leukoreduction of blood components | Q34977569 | ||
| The Use of Solvent/Detergent Treatment in Pathogen Reduction of Plasma | Q35095666 | ||
| Fatalities caused by TRALI. | Q35833541 | ||
| Predicting hemorrhage using preoperative coagulation screening assays. | Q35876473 | ||
| Paucity of studies to support that abnormal coagulation test results predict bleeding in the setting of invasive procedures: an evidence-based review | Q36244563 | ||
| Blood product transfusions and clinical outcomes in pediatric patients with acute lung injury | Q36650277 | ||
| Current risks of transfusion-transmitted agents: a review | Q36815106 | ||
| Transfusion-related immunomodulation (TRIM): an update | Q36931168 | ||
| The evidence-based use of FFP and cryoprecipitate for abnormalities of coagulation tests and clinical coagulopathy | Q37007311 | ||
| Minimal effects of acute liver injury/acute liver failure on hemostasis as assessed by thromboelastography. | Q37093069 | ||
| Evidence for indications of fresh frozen plasma | Q37145500 | ||
| Recommendations for the transfusion of plasma and platelets | Q37209117 | ||
| Appropriateness of fresh-frozen plasma usage in hospital settings: a meta-analysis of the impact of organizational interventions. | Q37589646 | ||
| Principles and practice of thromboelastography in clinical coagulation management and transfusion practice | Q37923011 | ||
| The plasma wars: a history | Q38009416 | ||
| Pediatric trauma BIG score: predicting mortality in children after military and civilian trauma | Q39769766 | ||
| Coagulation factor content of plasma produced from whole blood stored for 24 hours at ambient temperature: results from an international multicenter BEST Collaborative study. | Q43744630 | ||
| Widespread use of fresh frozen plasma in US children's hospitals despite limited evidence demonstrating a beneficial effect | Q44018998 | ||
| Predefined massive transfusion protocols are associated with a reduction in organ failure and postinjury complications. | Q44253763 | ||
| Association between plasma transfusions and clinical outcome in critically ill children: a prospective observational study | Q44378745 | ||
| Transfusion of fresh frozen plasma in critically ill surgical patients is associated with an increased risk of infection | Q44398924 | ||
| Evaluation and comparison of coagulation factor activity in fresh-frozen plasma and 24-hour plasma at thaw and after 120 hours of 1 to 6°C storage. | Q46026476 | ||
| A high ratio of plasma and platelets to packed red blood cells in the first 6 hours of massive transfusion improves outcomes in a large multicenter study | Q46132931 | ||
| The impact of perioperative transfusion of blood products on survival after pediatric liver transplantation | Q48177340 | ||
| Impact of platelets and fresh frozen plasma in contrast to red cell concentrate on unstimulated and stimulated cytokine release in an in vitro model of transfusion. | Q50602112 | ||
| Adverse outcomes of blood transfusion in children: analysis of UK reports to the serious hazards of transfusion scheme 1996-2005. | Q50657081 | ||
| Are multiple blood transfusions really a cause of acute respiratory distress syndrome? | Q50715818 | ||
| Effect of fresh-frozen plasma transfusion on prothrombin time and bleeding in patients with mild coagulation abnormalities. | Q50723641 | ||
| Fresh frozen plasma transfusion in critically ill patients. | Q53235779 | ||
| Toward rational fresh frozen plasma transfusion: The effect of plasma transfusion on coagulation test results. | Q53254548 | ||
| Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant | Q56675460 | ||
| Evaluation of coagulation abnormalities in acute liver failure | Q60696843 | ||
| Composition of fresh frozen plasma | Q69994885 | ||
| Practice parameter for the use of fresh-frozen plasma, cryoprecipitate, and platelets. Fresh-Frozen Plasma, Cryoprecipitate, and Platelets Administration Practice Guidelines Development Task Force of the College of American Pathologists | Q72257155 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 16 | |
| P577 | publication date | 2013-06-02 | |
| P1433 | published in | Annals of Intensive Care | Q18712109 |
| P1476 | title | Plasma in the PICU: why and when should we transfuse? | |
| P478 | volume | 3 |
| Q38409495 | Activity-based costs of plasma transfusions in medical and surgical inpatients at a US hospital |
| Q26741073 | Health Technology Assessment of pathogen reduction technologies applied to plasma for clinical use |
| Q41093063 | Indications and Effects of Plasma Transfusions in Critically Ill Children |
| Q91067835 | Plasma for direct therapeutic use, for today and tomorrow: A short critical overview |
Search more.